Third Trimester Amniotic Fluid Cells with the Capacity to Develop Nerual Phenotypes and with Heterogenicity among sub-populations.

Restor Neurol Neurosci. 30: 55-68

Collection and characterization of amniotic fluid from scheduled C-section deliverie.

Cell Tissue Bank. 17: 413-425

Routine Clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications.

Prenat Diagn. 33: 921-928Panero A.J. Hirahara A.M. Andersen W.J. et al.

Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for Mesenchymal Stem Cells With Bone Marrow.

Am J Sports Med. 47: 1230-1235Kern S. Eichler H. Stoeve J. et al.

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Stem Cells. 24: 1294-1301Montesinos J.J. Flores-Figueroa E. Castillo-Medina S. et al.

Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression.

Cytotherapy. 11: 163-176Moretti P. Hatlapatka T. Marten D. et al.

Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications.

Adv Biochem Eng Biotechnol. 123: 29-54Secunda R. Vennila R. Mohanashankar A.M. et al.

Isolation, expansion and characterization of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.

Cytotechnology. 67: 793-807Zeddou M. Briquet A. Relic B. et al.

The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.

Cell Biol Int. 34: 693-701Rebelatto C.K. Aguiar A.M. Moretao M.P. et al.

Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.

Exp Biol Med (Maywood). 233: 901-913Lu L.L. Liu Y.J. Yang S.G. et al.

Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.

Haematologica. 91: 1017-1026La Rocca G. Anzalone R. Corrao S. et al.

Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.

Histochem Cell Biol. 131: 267-282Weiss M.L. Medicetty S. Bledsoe A.R. et al.

Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease.

Stem Cells. 24: 781-792Baksh D. Song L. Tuan R.S.

Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy.

J Cell Mol Med. 8: 301-316Baksh D. Yao R. Tuan R.S.

Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.

Stem Cells. 25: 1384-1392Chen M.Y. Lie P.C. Li Z.L. et al.

Endothelial differentiation of Wharton’s jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.

Exp Hematol. 37: 629-640Kim M.J. Shin K.S. Jeon J.H. et al.

Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Cell Tissue Res. 346: 53-64

Bone-grafting and bone-graft substitutes.

J Bone Joint Surg Am. 84: 454-464Zhang H. Yang L. Yang X.G. et al.

Demineralized Bone Matrix Carriers and their Clinical Applications: An Overview.

Orthop Surg. 11: 725-737Campana V. Milano G. Pagano E. et al.

Bone substitutes in orthopaedic surgery: from basic science to clinical practice.

J Mater Sci Mater Med. 25: 2445-2461Gruskin E. Doll B.A. Futrell F.W. et al.

Demineralized bone matrix in bone repair: history and use.

Adv Drug Deliv Rev. 64: 1063-1077

Inductive substratum for osteogenesis in pellets of particulate bone matrix.

Clin Orthop Relat Res. 61: 61-78

Senn on the Healing of Aseptic Bone Cavities by Implantation of Antiseptic Decalcified Bone.

Ann Surg. 10: 352-368

Characteristics, Properties, and Functionality of Fetal Membranes: An Overlooked Area in the Field of Parturition. Encyclopedia of Reproduction.

2nd Edition. Elsevier,

Extracellular matrix dynamics and fetal membrane rupture.

Reprod Sci. 20: 140-153Hanselman A.E. Lalli T.A. Santrock R.D.

Topical Review: Use of Fetal Tissue in Foot and Ankle Surgery.

Foot Ankle Spec. 8: 297-304Ferguson V.L. Dodson R.B.

Bioengineering aspects of the umbilical cord.

Eur J Obstet Gynecol Reprod Biol. 144: S108-S113Taghizadeh R.R. Cetrulo K.J. Cetrulo C.L.

Wharton's Jelly stem cells: future clinical applications.

Placenta. 32: S311-S315Sobolewski K. Małkowski A. Bańkowski E. et al.

Wharton's jelly as a reservoir of peptide growth factors.

Placenta. 26: 747-752Ang J. Liou C.D. Schneider H.P.

The Role of Placental Membrane Allografts in the Surgical Treatment of Tendinopathies.

Clin Podiatr Med Surg. 35: 311-321Riboh J.C. Saltzman B.M. Yanke A.B. et al.

Human Amniotic Membrane-Derived Products in Sports Medicine: Basic Science, Early Results, and Potential Clinical Applications.

Am J Sports Med Sep. 44: 2425-2434Leal-Marin S. Kern T. Hofmann N. et al.

Human Amniotic Membrane: A review on tissue engineering, application, and storage.

J Biomed Mater Res B Appl Biomater. 109: 1198-1215Kesting M.R. Wolff K.D. Hohlweg-Majert B. et al.

The role of allogenic amniotic membrane in burn treatment.

J Burn Care Res. 29: 907-916Food, Drug Administration H.H.S.

Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.

Fed Regist. 69: 68611-68688Huddleston H.P. Cohn M.R. Haunschild E.D. et al.

Amniotic Product Treatments: Clinical and Basic Science Evidence.

Curr Rev Musculoskelet Med. 13: 148-154Rodriguez-Ares M.T. Lopez-Valladares M.J. Tourino R. et al.

Effects of lyophilization on human amniotic membrane.

Acta Ophthalmol. 87: 396-403Nakamura T. Yoshitani M. Rigby H. et al.

Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction.

Invest Ophthalmol Vis Sci. 45: 93-99Liu C. Bai J. Yu K. et al.

Biological Amnion Prevents Flexor Tendon Adhesion in Zone II: A Controlled, Multicentre Clinical Trial.

Biomed Res Int. 2019: 2354325Koob T.J. Rennert R. Zabek N. et al.

Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing.

Int Wound J. 10: 493-500Koob T.J. Lim J.J. Massee M. et al.

Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration.

Vasc Cell. 6: 10Gaspar M.P. Abdelfattah H.M. Welch I.W. et al.

Recurrent cubital tunnel syndrome treated with revision neurolysis and amniotic membrane nerve wrapping.

J Shoulder Elbow Surg. 25: 2057-2065Altman R.D. Manjoo A. Fierlinger A. et al.

The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review.

BMC Musculoskelet Disord. 16: 321Panero A.J. Hirahara A.M. Andersen W.J. et al.

Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for Mesenchymal Stem Cells With Bone Marrow Comparison.

Am J Sports Med. 47: 1230-1235Becktell L. Matuska A.M. Hon S. et al.

Proteomic Analysis and Cell Viability of Nine Amnion, Chorion, Umbilical Cord, and Amniotic Fluid-Derived Products.

Cartilage. 13: 495S-507SNiknejad H. Deihim T. Solati-Hashjin M. et al.

The effects of preservation procedures on amniotic membrane's ability to serve as a substrate for cultivation of endothelial cells.

Cryobiology. 63: 145-151

Injectable bone marrow preparations to stimulate osteogenic repair.

Clin Orthop Relat Res. 313: 8-18

U.S. National Library of Medicine. 2022.

US Department of Health and Human Services, Food and Drug Administration

Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use.

()

Allograft Tissues (pp 89-101).

in: Williams C. Sussman W. Pitts J. Atlas of interventional orthopedics procedures. Elsevier, United StatesZelen C.M. Poka A. Andrews J.

Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis-a feasibility study.

Foot Ankle Int. 34: 1332-1339Cazzell S. Stewart J. Agnew P.S. et al.

Randomized Controlled Trial of Micronized Dehydrated Human Amnion/Chorion Membrane (dHACM) Injection Compared to Placebo for the Treatment of Plantar Fasciitis.

Foot Ankle Int. 39: 1151-1161Hanselman A.E. Tidwell J.E. Santrock R.D.

Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study.

Foot Ankle Int. 36: 151-158Main B.J. Maffulli N. Valk J.A. et al.

Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review.

Pharmaceuticals (Basel). 14

Extracellular Vesicles: Exososomes, microvesicles, and friends.

J Cell Biol. 200: 373-383Hristove M. Erl W. Linder S. et al.

Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro.

Blood. 104: 2761-2766György B. Szabó T.G. Pásztói M. et al.

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.

Cell. Mol. Life Sci. 68: 2667-2688

Wang M Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis.

Cells. 8: 727

Exosome-mediated transfer of mRNAs and microRNA is a novel mechanism of genetic exchange between cells.

Nat Cell Biol. 9: 654-659Maas S. Breakenfield X. Weaver A.

Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Trends Cell Biol. 27: 172-188

Using exosomes, naturally-equipped nanocarriers, for drug delivery.

J Controlled Release. 219: 396-405Borges F.T. Melo S.A. Özdemir B.C. et al.

TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis.

J Am Soc Nephrol. 24: 385-392Rabinowits G. Gercel-Taylor C. Day J.M. et al.

Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer.

Clin Lung Cancer. 10: 42-46Akers J.C. Ramakrishnan V. Kim R. et al.

miR-21 in the extracellular vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development.

PLoS ONE. 8: e78115

Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and alpha Granules.

Blood. 94: 3791-3799

Platelet-Derived Exosomes and Atherothrombosis.

Front Cardiovasc Med. 9: 886132Koupenova M. Clancy L. Corkrey H.A. et al.

Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.

Circ Res. 122: 337-351

Comparison and Investigation of Exosomes Derived from Platelet Rich Plasma Activated by Different Agonist.

Cell Transplantation. 30: 1-13Milioli M. Ib'an˜ez-Vea M. Sidoli S. et al.

Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists.

J Proteomics. 121: 56-66Lyu H. Guo Q. Huang Y. et al.

The Role of Bone-Derived Exosomes in Regulating Skeletal Metabolism and Extraosseous Diseases.

Front Cell Developmental Biol. 8: 89

A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model.

Biomed Res Int Voume. 2021: 9688138Muller L. Hong C.-S. Stolz D.B. et al.

Isolation of Biologically-Active Exosomes from Human Plasma.

J Immunol Methods. 411: 55-65Livshits M.A. Khomyakova E. Evtushenko E.G. et al.

Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol.

Sci Rep. 5: 17319Vlassov A.V. Zeringer E. Barta T. et al.

Strategies for Isolation of Exosomes.

Cold Spring Harb Protoc. 2015: 319-323

VAST Clinical Trial : Safely Supplementing Tissue Lost to Degenerative Disc Disease.

Int J Spine Surg. 14: 239-253